Navigation Links
Bio-Matrix Scientific Group, Inc. Highlighted in LifeSciencesWorld.com Special Report; Stem Cell Market Projected to Exceed $8 Billion Worldwide by 2016
Date:3/3/2009

SAN DIEGO, March 3 /PRNewswire-FirstCall/ -- Bio-Matrix Scientific Group, Inc. (OTC Bulletin Board: BMSN) (http://www.BMSN.us), an emerging research and development biotechnology company focused on the full spectrum of adult stem cells at its commercial cryogenic stem cell bank and processing facility located here, is highlighted in a News/Special Report about trends in adult stem cells published this week as an exclusive to online LifeSciencesWorld (http://www.LifeSciencesWorld.com) that projects the overall market to exceed $8 billion worldwide by 2016 and the umbilical cord blood market estimated to reach approximately $1 billion by 2010.

The Special Report, "Discoveries of Stem Cell Derived from Menstrual Blood Significant Step Forward to Transplantation as Industry Focuses on Other Principle Sources in Therapeutics" by New York City-based author and writer Sally Robbins, provides an overview of the sector, including how a new type of stem cell derived from menstrual blood and other discoveries are providing significant steps forward in providing an ethical, easily accessible, and potentially highly useful adult stem cell for treatment of numerous degenerative conditions.

David Koos, Chairman and CEO of BMSN, is quoted in the report stating: "The recent discovery of the novel stem cell population in menstrual blood and related findings are scientific breakthroughs that are opening the doors to a new dimension in private stem cell/family banking, which has been primarily focused on umbilical cord blood." The report also reviews how BMSN is poised for growth by focusing on the full scope of adult stem cells: cord blood, peripheral blood, bone marrow, menstrual blood and adipose (fat) tissue by forging strategic partnerships in bringing together the necessary resources to offer key technologies in stem cell cryogenics, therapies and bio-medical devices for improving the quality of life.

The article also chronicles in-depth the new developments in umbilical cord blood technologies and the ways in which private stem cell banks in the industry are consolidating.

About Bio-Matrix Scientific Group

Bio-Matrix Scientific Group Inc. (OTCBB: BMSN) is a biotech research and development company that commercializes medical devices and monitoring systems for the growing worldwide stem cell research market. Its new facility houses two secure cryogenic stem cell banks, three research laboratories, aseptic cellular/tissue class 10,000/100 processing lab, hematology, microbiology and flow cytometry laboratories.

Disclaimer

This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.


'/>"/>
SOURCE Bio-Matrix Scientific Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Bio-Matrix Scientific Group Featured as Stock Pick in Oakleys Column on WallStreetCorner.com
2. Bio-Matrix Scientific Group Announces New Hires to Management Team
3. Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge
4. Edmond Scientific Company Spotlight on the Executive:
5. Bert W. OMalley, M.D., Recipient of the 2008 National Medal for Science, Joins Bionovos Scientific Advisory Board
6. Former SADMERC Medical Directors Join OrthoCare Innovations as Medical and Scientific Advisory Board Members and Strategic Advisors
7. Weed Science Society of America Announces Winners in Annual Scientific Awards Program
8. Arts Way Manufacturing Announces Launch of New Web Site For Arts Way Scientific - Buildings For Science
9. AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences
10. Sigma-Aldrich Signs Agreement With CPC Scientific for the Distribution of PEPscreen(R) Custom Peptide Libraries
11. BioSpace Partners with Journal of Visualized Experiments (JoVE) to Offer Peer-Reviewed Scientific Video Content on BioSpace.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , ... June 23, 2016 , ... In a new ... in Denmark detail how a patient who developed lymphedema after being treated for breast ... results could change the paradigm for dealing with this debilitating, frequent side effect of ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
Breaking Biology News(10 mins):